BIOMAT Database Logo BIOMAT Database Logo

[The new antitubercular drugs derived from isoniazid]. 1960

P GUILLEMAN

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

P GUILLEMAN
[THE NEW ANTITUBERCULAR DRUGS].
January 1964, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
P GUILLEMAN
Antitubercular drugs (isoniazid, rifampin and pyrazinamide): hepatobiliary reactions.
October 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
P GUILLEMAN
[New antitubercular drugs].
January 1990, Pneumonologia polska,
P GUILLEMAN
[Phenotype of isoniazid acetylation and tolerance of antitubercular drugs].
January 1988, Problemy tuberkuleza,
P GUILLEMAN
Synthesis, antitubercular evaluation, and molecular docking studies of hybrid pyridinium salts derived from isoniazid.
May 2023, Drug development research,
P GUILLEMAN
Prospects for new antitubercular drugs.
October 2004, Current opinion in microbiology,
P GUILLEMAN
[New drugs in antitubercular therapy].
January 1969, Helvetica medica acta. Supplementum,
P GUILLEMAN
Requirements of new antitubercular drugs from the experimental point of view.
February 1963, Annals of the New York Academy of Sciences,
P GUILLEMAN
[On antitubercular prevention with isoniazid].
January 1968, Annali dell'Istituto "Carlo Forlanini",
P GUILLEMAN
NEW and nonofficial drugs; isoniazid.
February 1953, Journal of the American Medical Association,
Copied contents to your clipboard!